Comparison of the effects of Valsalva maneuver,EMLA cream,and the combination of both in relieving pain of needle insertion on totally implantable access port: A randomized controlled study

Abstract

Background:

Totally implantable access port (TIAP) is a subcutaneously implanted, long-term infusion device that is widely used in oncology patients. However, multiple needle insertions into TIAP may lead to pain, anxiety, and dread in patients. This study aimed to compare the effectiveness of Valsalva maneuver, eutectic mixture of local anesthetics (EMLA) cream, and the combination of both in relieving pain of cannulations on TIAP.

Methods:

This was a prospective randomized controlled study. We included 223 patients treated with antineoplastic drugs and randomized them into four groups: EMLA Group (Group E), control Group (Group C), Valsalva maneuver Group (Group V), and EMLA cream combing with Valsalva maneuver Group (Group EV). Each group was given the corresponding intervention before non-coring needle insertion. The data on pain scores and overall comfort were collected by numerical pain rating scale (NPRS) and visual analog scale (VAS).

Results:

Group E and Group EV experienced the least amount of pain scores in needle insertion, which was significantly lower than Group V and Group C (p < 0.05). Meanwhile, Group E and Group EV obtained the highest comfort level, which was significantly higher than group C (p < 0.05). Fifteen patients developed localized skin erythema after the application of medical Vaseline or EMLA cream and subsided within half an hour after rubbing.

Conclusion:

EMLA cream is a safe and effective way to alleviate pain during non-coring needle insertion in TIAP and enhance the overall comfort of patients. We recommend applying EMLA cream 1 h before needle insertion of TIAP, especially in patients having needle phobia or high pain scores from previous non-coring needle insertion.

Keywords

Valsalva maneuver EMLA totally implantable access port (TIAP)pain comfort

Get full access to this article

View all access options for this article.

References

Shanghai Cooperation Group on Central Venous Access. Shanghai expert consensus on totally implantable access port. J Intervent Radiol 2015; 24(12): 1029–1033.

Capozzi

Monfardini

Sozzi

, et al. Peripherally inserted central venous catheters (PICC) versus totally implantable venous access device (PORT) for chemotherapy administration: a meta-analysis on gynecological cancer patients. Acta bio-medica: Atenei Parmensis 2021; 92(5): e2021257.

Wen

Wan

. Effects analysis of implanting intravenous infusion port and PICC in patients with breast cancer undergoing chemotherapy. Nurs Prac Res 2018; 15(04): 132–133.

Shanghai Cooperation Group on Central Venous Access, Expert Committee on Vascular Access, Committee of Experts on Focused Diagnosis and Treatment of Solid Tumors, Shanghai Anti-Cancer Association. Consensus of Shanghai experts on totally implantable access port. J Intervent Radiol 2019; 28(12): 1123–1128.

Bertoglio

. Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: it is time for a change. J Vasc Access 2021; 22(5): 689–691.

Huang

Liu

, et al. Observation on the application of local ice compress in the puncture of patients with indwelling infusion port using no injury needle. J Nurse Train 2016; 31(19):1793–1794.

Burbridge

Lim

Dwernychuk

, et al. Comparison of the quality of life of patients with breast or colon cancer with an arm vein port (TIVAD) versus a peripherally inserted central catheter (PICC). Curr Oncol 2021; 28(2): 1495–1506.

Moureau

Zonderman

. Does it always have to hurt? Premedications for adults and children for use with intravenous therapy. J Intraven Nurs 2000; 23(4): 213–219.

Dun

Liu

. The relationship between pain sensation, emotion and cognition in cancer patients. Int J Nurs 2021; 40(13): 2335–2338.

10.

Kettwich

Sibbitt

Brandt

, et al. Needle phobia and stress-reducing medical devices in pediatric and adult chemotherapy patients. J Pediatr Oncol Nurs 2007; 24(1): 20–28.

11.

Huang

Ren

. Observation on the effect of modified Valsalva maneuver in reducing pain when inserting butterfly wing needle in infusion port. J Bengbu Med Coll 2017; 42(10): 1419–1420.

12.

Yin

Jiang

. Evaluation of EMLA cream for relieving pain during needle insertion on totally implantable venous access device. J Vasc Access 2018; 19(6): 634–638.

13.

Suren

Kaya

Ozkan

, et al. Comparison of the use of the Valsalva maneuver and the eutectic mixture of local anesthetics (EMLA®) to relieve venipuncture pain: a randomized controlled trial. J Anesth 2012; 27(3): 407–411.

14.

Hobek

Kus

Dogukan

. Effects of Valsalva Maneuver, EMLA cream, and stress ball for pregnant women’s venipuncture pain. Altern Ther Health Med 2021; 27(5): 108–114.

15.

Zheng

. Effect of cold spray on relieving pain of non-invasive needle puncture. J Wenzhou Med Univer 2014; 44(12): 920–921.

16.

Zhang

Zhu

Qin

. Observation on the effect of aerosol-type skin cold spray in relieving the pain of patients with non-invasive needle venipuncture at the infusion port. J Nurses Train 2019; 34(24): 2282–2283.

17.

Basaranoglu

Erden

, et al. The effects of Valsalva manoeuvres on venepuncture pain. Eur J Anaesthesiol 2006; 23(7): 591–593.

18.

Faul

Erdfelder

Lang

, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39(2): 175–191.

19.

Wang

Zhao

. Efifcacy and safety of lidocaine cataplasms 5%for the treatment of post-herpetic neuralgia. J Prac Dermat 2015; 8(3): 181–184.

20.

Kock

Pietsch

Krause

, et al. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998; 22(1): 12–16.

21.

Kong

Zhang

Chu

. Clinical effect of venous-access ports and PICC in patients with tumor chemotherapy:a systematic evaluation. Chin Nurs Res 2018; 32(9): 1407–1414.

22.

. Observation on the analgesic effect of compound lidocaine cream for puncture of non-invasive needle. Strait Pharm J 2011; 23(11): 117–118.

23.

Duncanson

Le Leu

Shanahan

, et al. The prevalence and evidence-based management of needle fear in adults with chronic disease: a scoping review. PLoS One 2021; 16(6): e0253048.

24.

Sokolowski

Giovannitti

Boynes

. Needle phobia: etiology, adverse consequences, and patient management. Dent Clin North Am 2010; 54(4): 731–744.

25.

Drug.com. EMLA Prescribing Information[EB/OL]. (2022-7-1)[2022-10-08]. https://www.drugs.com/pro/emla.html.

26.

Srivastava

Kumar

Agarwal

, et al. Evaluation of efficacy of Valsalva for attenuating needle puncture pain in first time nonremunerated voluntary plateletpheresis donors: a prospective, randomized controlled trial. Asian J Transfus Sci 2021; 15(1): 68–74.